Expert Rev Mol Diagn. 2010;10(6):755-763. The diagnosis is based on a three-step strategy. The first step is recognizing clinical signs and symptoms. Many symptoms in various combinations may suggest ...
Researchers at the University of São Paulo (USP) in Brazil have discovered that two osteoporosis drugs (etidronate and tiludronate) may combat diseases caused by iron accumulation in the body. In ...
Hosted on MSN
Living with hemochromatosis and taking back control
Hemochromatosis is a genetic or secondary condition where the body absorbs and stores too much iron, slowly damaging vital organs. Early signs can be subtle, but untreated cases may lead to severe ...
Researchers at the University of São Paulo (USP) in Brazil have discovered that two osteoporosis drugs (etidronate and tiludronate) may combat diseases caused by iron accumulation in the body. In ...
The Hep25/FP system classifies PIOSs as prehepatic ACP and ILA, hepatic HC, and posthepatic SLC40A1-HC and FP-D. The clinical introduction of hepcidin25 (Hep25) has led to a more detailed ...
People from the Outer Hebrides and north-west Ireland have the highest risk of developing a genetic disease that causes a dangerous build-up of iron in the body, a study published in the journal ...
Researchers at the University of São Paulo (USP) in Brazil have discovered that two osteoporosis drugs (etidronate and tiludronate) may combat diseases caused by iron accumulation in the body. In ...
Study reveals liraglutide's potential to regulate iron metabolism and improve glucose tolerance in a mouse model of hereditary hemochromatosis and obesity. Study: Liraglutide Impacts Iron Homeostasis ...
Multi-echo T2* MRI identifies neonatal haemochromatosis through thyroid and pancreatic iron patterns in neonatal liver ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results